Released Aug 10, 2016, before the open
10-Q filed Aug 10, 2016, 41 days after period end · 0001193125-16-677550
Q2 2016 · 10-Q
Revenue—
Net Income-$8.68M-$8.68M N/M vs Q2 2015N/M vs Q1 2016
EPS Diluted-$0.33-$0.33 N/M vs Q2 2015N/M vs Q1 2016
Operating Income-$8,780,000N/M
Operating Cash Flowderived-$8,003,000N/M
Free Cash Flowderived-$8,224,000—
What the release said
The release
Same quarter
| Metric | Q2 2016 | Q2 2015 | Q2 2014 |
|---|---|---|---|
| Net Income | -$8.68M | -$2.39M | -$2.85M |
| EPS Diluted | -$0.33 | -$0.15 | -$3.81 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rocket Pharmaceuticals, Inc. · CIK 1281895 · Engraved from SEC EDGAR